
Keiretsu Forum Northwest
Description
Keiretsu Forum Northwest stands as a leading angel investor network based in Seattle, Washington, serving as a vital component of the broader global Keiretsu Forum organization. This chapter is specifically recognized as the largest and most active angel investor network within the Pacific Northwest region. Its investment focus spans a diverse range of early-stage companies, primarily concentrating on innovative ventures in technology, promising real estate projects, and advancements in medical devices. The network's strength lies in its collaborative model, bringing together accredited investors who pool their capital and expertise to support nascent enterprises.
Since its inception, the Keiretsu Forum Northwest chapter has demonstrated significant impact on the regional startup ecosystem. It has successfully deployed over $100 million in capital, providing crucial funding to more than 200 early-stage companies. This substantial financial commitment underscores its dedication to fostering innovation and economic growth across its target sectors. The network's rigorous due diligence process ensures that only thoroughly vetted opportunities are presented to its members, enhancing the quality and potential of their investment portfolio.
The typical first cheque size for companies receiving investment from Keiretsu Forum Northwest members ranges from $250,000 to $2,000,000. This range reflects their commitment to providing meaningful early-stage capital that can significantly propel a startup's development. Beyond financial investment, Keiretsu Forum Northwest offers its portfolio companies access to a vast network of experienced entrepreneurs, industry experts, and strategic partners, providing invaluable mentorship and operational guidance. This comprehensive support system is designed to maximize the success potential of the ventures they back, making them a significant partner for emerging businesses in the Pacific Northwest.
Investor Profile
Keiretsu Forum Northwest has backed more than 175 startups, with 0 new investments in the last 12 months alone. The firm has led 9 rounds, about 5% of its total and boasts 24 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States, Spain, Canada.
- Strong thematic focus on Software, Health Care, Biotechnology.
- Typical check size: $250K – $2M.
Stage Focus
- Series Unknown (35%)
- Series A (29%)
- Seed (18%)
- Angel (6%)
- Series B (5%)
- Convertible Note (3%)
- Private Equity (1%)
- Series C (1%)
- Grant (1%)
- Pre Seed (1%)
Country Focus
- United States (82%)
- Spain (5%)
- Canada (4%)
- Israel (3%)
- United Kingdom (1%)
- Ireland (1%)
- Turkey (1%)
- India (1%)
- China (1%)
- Sweden (1%)
Industry Focus
- Software
- Health Care
- Biotechnology
- Manufacturing
- Enterprise Software
- Saas
- Medical
- Medical Device
- Information Technology
- Real Estate
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.